Mar 14, 2023 / 12:00PM GMT
Luke England Sergott - Barclays Bank PLC, Research Division - Research Analyst
Right. I guess we can get started. Good morning, everybody. Welcome to Miami. Thank you for coming, first day, kicking it off here with Dr. Prahlad Singh of PerkinElmer.
Maybe if you just want to start off and give some real high-level takeaways from the quarter, and how the year is progressing for you guys, and then we can start digging in.
Prahlad R. Singh - PerkinElmer, Inc. - CEO, President & Director
Yes. I mean as we've talked about at the beginning when we did our earnings call, we are excited about the year. We are excited about our strategy. I mean, I'm sure most, if not all of you, saw the announcement and the close of the divestiture of our applied enterprise and services business.
And we've set up the company to be a pure-play life sciences and diagnostics business, which is high growth and high margin. And that was essentially stage 1 of the culmination of the transformation process that we started many years ago. And we've set the company up really
PerkinElmer Inc at Barclays Global Healthcare Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers